Skip to content

Line	Code	2024	2025	Change	%
Total assets	20/58	€26,694,164	€27,269,215	+€575,051	+2.2%
Fixed assets	21/28	€11,157,981	€12,633,638	+€1.5m	+13.2%
Tangible fixed assets	22/27	€7,570,870	€9,573,902	+€2.0m	+26.5%
Land and buildings	22	€0	-	=
Plant, machinery and equipment	23	€6,254,052	€8,800,792	+€2.5m	+40.7%
Furniture and vehicles	24	€407,934	€359,523	-€48,411	-11.9%
Leasing and similar rights	25	€0	€0	=
Assets under construction and advance payments	27	€908,884	€413,587	-€495,297	-54.5%
Financial fixed assets	28	€3,587,111	€3,059,736	-€527,375	-14.7%
Affiliated companies	280/1	€3,585,611	€3,058,236	-€527,375	-14.7%
Amounts receivable	281	€3,585,611	€3,058,236	-€527,375	-14.7%
Other financial fixed assets	284/8	€1,500	€1,500	=	0.0%
Amounts receivable and cash guarantees	285/8	€1,500	€1,500	=	0.0%
Current assets	29/58	€15,536,183	€14,635,577	-€900,606	-5.8%
Stocks and contracts in progress	3	€8,393,750	€8,798,810	+€405,060	+4.8%
Stocks	30/36	€8,393,750	€8,798,810	+€405,060	+4.8%
Raw materials and consumables	30/31	€2,254,433	€2,314,388	+€59,955	+2.7%
Work in progress	32	€1,096,519	€1,482,712	+€386,193	+35.2%
Finished goods	33	€5,042,798	€5,001,710	-€41,088	-0.8%
Amounts receivable within one year	40/41	€6,805,654	€5,277,954	-€1.5m	-22.4%
Trade receivables	40	€6,360,559	€4,368,094	-€2.0m	-31.3%
Other amounts receivable	41	€445,095	€909,860	+€464,765	+104%
Cash at bank and in hand	54/58	€287,096	€504,854	+€217,758	+75.8%
Deferred charges and accrued income	490/1	€49,683	€53,959	+€4,276	+8.6%
Total equity and liabilities	10/49	€26,694,164	€27,269,215	+€575,051	+2.2%
Equity	10/15	€12,404,856	€14,497,083	+€2.1m	+16.9%
Contributions	10/11	€62,000	€62,000	=	0.0%
Capital	10	€62,000	€62,000	=	0.0%
Issued capital	100	€62,000	€62,000	=	0.0%
Reserves	13	€1,686,608	€2,686,610	+€1.0m	+59.3%
Non-distributable reserves	130/1	€18,137	€18,137	=	0.0%
Legal reserve	130	€6,200	€6,200	=	0.0%
Reserves not available under the articles	1311	€11,937	€11,937	=	0.0%
Tax-exempt reserves	132	€1,016,432	€2,016,434	+€1.0m	+98.4%
Distributable reserves	133	€652,039	€652,039	=	0.0%
Profit (loss) carried forward	14	€9,946,079	€11,128,772	+€1.2m	+11.9%
Investment grants	15	€710,169	€619,701	-€90,468	-12.7%
Provisions and deferred taxes	16	€72,136	€8,188	-€63,948	-88.6%
Provisions for liabilities and charges	160/5	€72,136	€8,188	-€63,948	-88.6%
Pensions and similar obligations	160	€17,230	€8,188	-€9,042	-52.5%
Other liabilities and charges	164/5	€54,906	€0	-€54,906	-100%
Amounts payable	17/49	€14,217,172	€12,763,944	-€1.5m	-10.2%
Amounts payable after more than one year	17	€2,531,602	€3,176,923	+€645,321	+25.5%
Financial debts	170/4	€2,531,602	€3,176,923	+€645,321	+25.5%
Credit institutions	173	€2,531,602	€3,176,923	+€645,321	+25.5%
Amounts payable within one year	42/48	€11,440,824	€9,376,325	-€2.1m	-18.0%
Current portion of amounts payable after more than one year	42	€1,215,321	€1,637,857	+€422,536	+34.8%
Financial debts	43	€2,980,000	€2,800,000	-€180,000	-6.0%
Credit institutions	430/8	€2,980,000	€2,800,000	-€180,000	-6.0%
Other loans	439	€0	€0	=
Trade debts	44	€4,686,520	€3,351,356	-€1.3m	-28.5%
Suppliers	440/4	€4,686,520	€3,351,356	-€1.3m	-28.5%
Advances received on contracts in progress	46	€532,218	€712,388	+€180,170	+33.9%
Taxes, remuneration and social security	45	€731,743	€818,032	+€86,289	+11.8%
Taxes	450/3	€7,925	€4,546	-€3,379	-42.6%
Remuneration and social security	454/9	€723,818	€813,486	+€89,668	+12.4%
Other amounts payable	47/48	€1,295,022	€56,692	-€1.2m	-95.6%
Accrued charges and deferred income	492/3	€244,746	€210,696	-€34,050	-13.9%
Operating income	70/76A	€42,516,545	€40,583,736	-€1.9m	-4.5%
Turnover	70	€41,314,464	€39,615,645	-€1.7m	-4.1%
Change in stocks of work in progress, finished goods and contracts in progress	71	-€471,268	€413,212	+€884,480
Other operating income	74	€667,844	€554,879	-€112,965	-16.9%
Non-recurring operating income	76A	€1,005,505	-	-€1.0m
Operating charges	60/66A	€37,811,231	€37,547,811	-€263,420	-0.7%
Goods for resale, raw materials and consumables	60	€19,615,288	€18,919,191	-€696,097	-3.5%
Purchases	600/8	€18,396,099	€19,126,383	+€730,284	+4.0%
Change in stocks: decrease (increase)	609	€1,219,189	-€207,192	-€1.4m
Services and other goods	61	€10,864,486	€10,042,006	-€822,480	-7.6%
Remuneration, social security and pensions	62	€6,208,342	€6,944,432	+€736,090	+11.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets	630	€1,002,439	€1,101,642	+€99,203	+9.9%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)	631/4	-€147,177	€224,903	+€372,080
Provisions for liabilities and charges: additions (uses and reversals)	635/8	€59,280	-€63,948	-€123,228
Other operating charges	640/8	€208,573	€379,585	+€171,012	+82.0%
Operating profit (loss)	9901	€4,705,314	€3,035,925	-€1.7m	-35.5%
Financial income	75/76B	€531,052	€341,614	-€189,438	-35.7%
Recurring financial income	75	€531,052	€341,614	-€189,438	-35.7%
Income from financial fixed assets	750	€92,031	€90,468	-€1,563	-1.7%
Other financial income	752/9	€439,021	€251,146	-€187,875	-42.8%
Financial charges	65/66B	€494,070	€423,574	-€70,496	-14.3%
Recurring financial charges	65	€494,070	€423,574	-€70,496	-14.3%
Debt charges	650	€400,441	€290,138	-€110,303	-27.5%
Other financial charges	652/9	€93,629	€133,436	+€39,807	+42.5%
Profit (loss) for the period before taxes	9903	€4,742,296	€2,953,965	-€1.8m	-37.7%
Income taxes	67/77	€1,233,492	€771,270	-€462,222	-37.5%
Taxes	670/3	€1,233,492	€894,860	-€338,632	-27.5%
Tax adjustments and reversals of tax provisions	77	-	€123,590	+€123,590
Profit (loss) for the period	9904	€3,508,804	€2,182,695	-€1.3m	-37.8%
Transfer to tax-exempt reserves	689	€999,997	€1,000,002	+€5	0.0%
Profit (loss) for the period to be appropriated	9905	€2,508,807	€1,182,693	-€1.3m	-52.9%

Desobry: value indication

Desobry: value indication

Position among the sector peers

What moved between 2024 and 2025

Largest movements

Change in the result, 2024 to 2025

Derived cash bridge

Value

Indicative value of the equity

Adjusted equity

Capitalised earnings

Your EBITDA multiple

Limits of the indication

Next steps